BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 28209946)

  • 21. Imatinib-Associated Tumor Lysis Syndrome in a Patient With Myeloid Neoplasm With Eosinophilia and PDGFRA Rearrangement: A Case Report and Review of the Literature.
    Socola F; Hawes V; Lobo RH; Sasapu A
    J Glob Oncol; 2018 Sep; 4():1-4. PubMed ID: 30241197
    [No Abstract]   [Full Text] [Related]  

  • 22. [Successful treatment with imatinib for a patient with myeloid neoplasms with eosinophilia and abnormalities of PDGFRB due to t (5;14)(q33;q22)].
    Fujii T; Ohno N; Matsui T; Kitahara S; Kobayashi S; Sahara N; Sakamoto N; Matsunaga T
    Rinsho Ketsueki; 2021; 62(11):1635-1638. PubMed ID: 34866089
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sustained Response to Imatinib in a Pediatric Patient with Concurrent Myeloproliferative Disease and Lymphoblastic Lymphoma Associated with a CCDC88C-PDGFRB Fusion Gene.
    Bielorai B; Leitner M; Goldstein G; Mehrian-Shai R; Trakhtenbrot L; Fisher T; Marcu V; Yalon M; Schiby G; Barel O; Cal N; Golan H; Toren A
    Acta Haematol; 2019; 141(2):119-127. PubMed ID: 30726835
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Myeloid/Lymphoid Neoplasm with PDGFRB Rearrangement with t (5;10) (q33;q22) Harboring a Novel Breakpoint of the CCDC6-PDGFRB Fusion Gene.
    Yamazaki M; Nakaseko C; Takeuchi M; Ozawa S; Ishizuka Y; Hatanaka Y; Oshima-Hasegawa N; Muto T; Tsukamoto S; Mitsukawa S; Ohwada C; Takeda Y; Mimura N; Iseki T; Fukazawa M; Sakaida E
    Intern Med; 2019 Dec; 58(23):3449-3453. PubMed ID: 31327842
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Myeloproliferative hypereosinophilic syndrome revealed by bipolar mucosal ulcerations].
    Isvy-Joubert A; Hickman G; Flageul B; Battistella M; Bagot M; Galicier L; Petit A
    Ann Dermatol Venereol; 2012 Oct; 139(10):636-40. PubMed ID: 23122377
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Recurrent CEP85L-PDGFRB fusion in patient with t(5;6) and imatinib-responsive myeloproliferative neoplasm with eosinophilia.
    Winkelmann N; Hidalgo-Curtis C; Waghorn K; Score J; Dickinson H; Jack A; Ali S; Cross NC
    Leuk Lymphoma; 2013 Jul; 54(7):1527-31. PubMed ID: 23186533
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long-term follow-up of treatment with imatinib in eosinophilia-associated myeloid/lymphoid neoplasms with PDGFR rearrangements in blast phase.
    Metzgeroth G; Schwaab J; Gosenca D; Fabarius A; Haferlach C; Hochhaus A; Cross NC; Hofmann WK; Reiter A
    Leukemia; 2013 Nov; 27(11):2254-6. PubMed ID: 23615556
    [No Abstract]   [Full Text] [Related]  

  • 28. A novel NAP1L4/NUTM1 fusion arising from translocation t(11;15)(p15;q12) in a myeloid neoplasm with eosinophilia and rearrangement of PDGFRA highlights an unusual clinical feature and therapeutic reaction.
    Cheng Z; Luo Y; Zhang Y; Wang Y; Chen Y; Xu Y; Peng H; Zhang G
    Ann Hematol; 2020 Jul; 99(7):1561-1564. PubMed ID: 32451710
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Imatinib mesylate lacks efficacy in relapsed/refractory peripheral T cell lymphoma.
    Jacobsen E; Pozdnyakova O; Redd R; Fisher DC; Dorfman DM; Dal Cin P; LaCasce A; Armand P; Hochberg E; Cote G; Shahsafaei A; Neuberg D; Brown JR; Freedman AS
    Leuk Lymphoma; 2015 Apr; 56(4):993-8. PubMed ID: 25012943
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The results of imatinib therapy for patients with primary eosinophilic disorders.
    Helbig G; Stella-Holowiecka B; Grosicki S; Bober G; Krawczyk M; Wojnar J; Reiter A; Hochhaus A; Holowiecki J
    Eur J Haematol; 2006 Jun; 76(6):535-6. PubMed ID: 16608506
    [No Abstract]   [Full Text] [Related]  

  • 31. Myeloid neoplasm with a novel cryptic PDGFRB rearrangement detected by next-generation sequencing.
    Zimmermann N; Nassiri M; Zhou J; Miller AM; Zhang S
    Cancer Genet; 2020 Jun; 244():55-59. PubMed ID: 32442889
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Targeted next generation sequencing of PDGFRB rearranged myeloid neoplasms with monocytosis.
    Patnaik MM; Lasho TL; Finke CM; Pardanani A; Tefferi A
    Am J Hematol; 2016 Mar; 91(3):E12-4. PubMed ID: 26662677
    [No Abstract]   [Full Text] [Related]  

  • 33. A rare cause of persistent leukocytosis with massive splenomegaly: Myeloid neoplasm with BCR-PDGFRA rearrangement-Case report and literature review.
    Gao L; Xu Y; Weng LC; Tian ZG
    Medicine (Baltimore); 2022 Jun; 101(24):e29179. PubMed ID: 35713428
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Molecular and cytogenetic characterization of a novel translocation t(4;22) involving the breakpoint cluster region and platelet-derived growth factor receptor-alpha genes in a patient with atypical chronic myeloid leukemia.
    Safley AM; Sebastian S; Collins TS; Tirado CA; Stenzel TT; Gong JZ; Goodman BK
    Genes Chromosomes Cancer; 2004 May; 40(1):44-50. PubMed ID: 15034867
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Therapy-related acute myeloid leukemia with eosinophilia, basophilia, t(4;14)(q12;q24) and PDGFRA rearrangement: a case report and review of the literature.
    Zhou J; Papenhausen P; Shao H
    Int J Clin Exp Pathol; 2015; 8(5):5812-20. PubMed ID: 26191303
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Myeloid Neoplasm with PCM1-PDGFRB Transcript Responded to Low-Dose Imatinib: One Case Report with Literature Review.
    Wang Z; Wan L; Lin D; Li CW; Tian Z; Mi YC
    Acta Haematol; 2022; 145(5):560-565. PubMed ID: 35340014
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Relapse of myeloid neoplasm with eosinophilia and PDGFRA rearrangement after imatinib discontinuation in a pediatric patient.
    Rathe M; Schomerus E; Wehner PS; Kristensen TK; Møller MB
    Pediatr Blood Cancer; 2014 Dec; 61(12):2328. PubMed ID: 25175494
    [No Abstract]   [Full Text] [Related]  

  • 38. Unique association of myeloid neoplasm with eosinophilia and abnormalities of PDGFRA with TTP.
    Chaudhary LN; Bailey NG; Vos JA; Stotler CJ
    W V Med J; 2013; 109(2):6-9. PubMed ID: 23600098
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Myeloid neoplasms associated with eosinophilia and rearrangement of PDGFRA, PDGFRB, and FGFR1: a review.
    Savage N; George TI; Gotlib J
    Int J Lab Hematol; 2013 Oct; 35(5):491-500. PubMed ID: 23489324
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A diagnostically difficult case of chronic myeloid neoplasm with eosinophilia and abnormalities of PDGFRA effectively treated with imatinib in accelerated phase: case report.
    Rodzaj M; Gałazka K; Majewski M; Zduńczyk A
    Pol Arch Med Wewn; 2009 Dec; 119(12):838-41. PubMed ID: 20010473
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.